Pfizer And Moderna Rally After FDA Grants Full Approval To Pfizer’s Covid-19 Vaccine

Pfizer climbed 4%, while its German vaccine partner, BioNTech, soared more than 10%.
Pfizer climbed 4%, while its German vaccine partner, BioNTech, soared more than 10%.